-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N56aS9pUXCtrlvr9HCiEPYQNP2UcYeyvZ4zcagjkJolTxQyGhsJAESBbUCiX7UcH 6feeHH7DltJIhosoSCOASQ== 0000950152-06-009518.txt : 20061117 0000950152-06-009518.hdr.sgml : 20061117 20061117092008 ACCESSION NUMBER: 0000950152-06-009518 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061117 DATE AS OF CHANGE: 20061117 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DYADIC INTERNATIONAL INC CENTRAL INDEX KEY: 0001213809 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 450486747 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80718 FILM NUMBER: 061224994 BUSINESS ADDRESS: STREET 1: 140 INTRACOASTAL POINTE DRIVE STREET 2: SUITE 404 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: 561-743-8333 MAIL ADDRESS: STREET 1: 140 INTRACOASTAL POINTE DRIVE STREET 2: SUITE 404 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: CCP WORLDWIDE INC DATE OF NAME CHANGE: 20030110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Abengoa Bioenergy R&D, Inc. CENTRAL INDEX KEY: 0001350279 IRS NUMBER: 364518466 STATE OF INCORPORATION: MO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1400 ELBRIDGE PAYNE STREET 2: SUITE 100 CITY: CHESTERFIELD STATE: MO ZIP: 63017 BUSINESS PHONE: 636.728.0508 MAIL ADDRESS: STREET 1: 1400 ELBRIDGE PAYNE STREET 2: SUITE 100 CITY: CHESTERFIELD STATE: MO ZIP: 63017 SC 13G 1 l23345asc13g.htm ABENGOA BIOENERGY R&D, INC./DYADIC INTERNATIONAL, INC. SC 13G sc13g
 

     
 
OMB APPROVAL
 
 
OMB Number: 3235-0145
 
 
Expires: February 28, 2009
 
 
Estimated average burden hours per response...11
 
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.     )*

Dyadic International, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
26745T101
(CUSIP Number)
NOVEMBER 8, 2006
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 
 


 

                     
CUSIP No.
 
 

 

           
1   NAMES OF REPORTING PERSONS:
Abengoa Bioenergy R&D, Inc.
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    36-4518466
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  Missouri
       
  5   SOLE VOTING POWER:
     
NUMBER OF   2,136,752
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   2,136,752
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  2,136,752
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  8.6%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  CO


 

ITEM 1(A). NAME OF ISSUER.
     Dyadic International, Inc., (the “Company”).
ITEM 1(B). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES.
140 Intracoastal Pointe Drive, Suite 404
Jupiter, Florida 33477
ITEMS 2(A). NAME OF PERSON FILING.
     This statement is filed on behalf of Abengoa Bioenergy R&D, Inc., a Missouri corporation (the “Reporting Person”), with respect to shares of common stock of the Company beneficially held by the Reporting Person.
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE.
     The address of the principal business office of the Reporting Person is 1400 Elbridge Payne, Suite 212, Chesterfield, MO 63017.
ITEM 2(C). CITIZENSHIP.
     The Reporting Person is incorporated in the State of Missouri.
ITEM 2(D). TITLE OF CLASS OF SECURITIES.
     Common Stock.
ITEM 2(E). CUSIP NUMBER.
     26745T101
ITEM 3.
     If this statement is filed pursuant to Rules 13d-1(b) or 13d- 2(b) or (c), check whether the person filing is a:
(a)   o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o),
 
(b)   o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c),
 
(c)   o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c),
 
(d)   o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8),
 
(e)   o Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(E),

 


 

(f)   o Employee benefit plan or endowment fund in accordance with 13d-1 (b)(1)(ii)(F),
 
(g)   o Parent holding company or control person in accordance with Rule 13d-1 (b)(1)(ii)(G),
 
(h)   o Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813),
 
(i)   o Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3),
 
(j)   o Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
ITEM 4. OWNERSHIP.
     The responses of the Reporting Person with respect to Rows 5, 6, 7, 8, 9 and 11 of the cover page to this Schedule 13G are incorporated herein by reference.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
     If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. o
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
     None.
ITEM 7.   IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
     Not Applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
     Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
     Not Applicable.
ITEM 10. CERTIFICATION.
     Not Applicable.

 


 

SIGNATURES
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
DATED: November 17, 2006
         
  ABENGOA BIOENERGY R&D, INC.
 
 
  /s/ Christopher G. Standlee    
  Christopher G. Standlee   
  Secretary   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----